Paid Clinical Trials for Parkinson Disease

Showing 21 – 40 of 87 results

Treating Parkinson’s Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons

by CTG

in Parkinson Disease

Other

Massachusetts

Deadline:

12/01/2028

Everyday Memory Impairment in PD-related Cognitive Decline

by CTG

in Mild Cognitive Impairment, Parkinson Disease

Other

Missouri

Deadline:

09/01/2026

A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson’s Disease

by CTG

in Parkinson Disease, Parkinson Disease, Idiopathic, Parkinson, Idiopathic Parkinson Disease, Early Parkinson Disease (Early PD)

Other

Arizona

Deadline:

09/01/2027

An Observational Study of Patients With Moderate Parkinson’s Disease

by CTG

in Parkinson Disease

Other

California

Deadline:

03/11/2030

HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson’s Disease (HOBSCOTCH-Parkinson’s)

by CTG

in Parkinson Disease, Cognitive Dysfunction, Memory Disorders

Other

New Hampshire

Deadline:

07/30/2026

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients

by CTG

in Parkinson Disease, Multiple System Atrophy, Autonomic Failure, Pure Autonomic Failure, Neurogenic Orthostatic Hypotension

Other

Tennessee

Deadline:

12/01/2026

Neocortical Microarchitecture of Executive Function

by CTG

in Parkinson Disease

Other

Colorado

Deadline:

12/01/2027

Effects of RAS on Gait in PD Patients With DBS

by CTG

in Parkinson Disease

Other

Maryland

Deadline:

04/01/2026

Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder

by CTG

in Parkinson Disease, REM Sleep Behavior Disorder, Dementia With Lewy Bodies

Other

Minnesota

Deadline:

09/01/2028

Closed Loop DBS Implanted RC+S Study

by CTG

in Parkinson Disease

Other

North Carolina

Deadline:

01/01/2027

Understanding Motivation in Parkinson’s Patients Through Neurophysiology

by CTG

in Parkinson Disease, Deep Brain Stimulation, Motivation

Other

California

Deadline:

12/01/2030

Intestinal Immunity in Neurologic Disease

by CTG

in Multiple Sclerosis, Parkinson Disease, REM Sleep Behavior Disorder

Other

Connecticut

Deadline:

08/31/2027

Imaging Core Aim 2, and Udall Project 2 Aim 2

by CTG

in Parkinson Disease

Other

Minnesota

Deadline:

07/31/2026

Genetics and Aerobic Exercise to Slow Parkinson’s Disease Trial

by CTG

in Parkinson Disease

Other

Ohio

Deadline:

12/31/2028

BOOST-PD A Naturalistic Study on IPX-203 for Parkinson’s Disease

by CTG

in Parkinson Disease

Other

Ohio

Deadline:

05/15/2027

Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease

by CTG

in Parkinson Disease

Other

Michigan

Deadline:

03/01/2026

Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)

by CTG

in Parkinson Disease, Huntington Disease

Other

Virginia

Deadline:

09/01/2026

Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson’s Disease

by CTG

in Parkinson Disease

Other

Florida

Deadline:

01/30/2027

Phase 1/2a Study of ANPD001 in Parkinson Disease

by CTG

in Parkinson Disease

Other

Arizona

Deadline:

04/30/2030

DB RCT for Specialized Phototherapy in Parkinson’s Disease.

by CTG

in Parkinson Disease

Other

New York

Deadline:

08/30/2026

Load more All clinical trials loaded.

Treating Parkinson’s Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons

Everyday Memory Impairment in PD-related Cognitive Decline

A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson’s Disease

An Observational Study of Patients With Moderate Parkinson’s Disease

HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson’s Disease (HOBSCOTCH-Parkinson’s)

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients

Neocortical Microarchitecture of Executive Function

Effects of RAS on Gait in PD Patients With DBS

Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder

Closed Loop DBS Implanted RC+S Study

Understanding Motivation in Parkinson’s Patients Through Neurophysiology

Intestinal Immunity in Neurologic Disease

Imaging Core Aim 2, and Udall Project 2 Aim 2

Genetics and Aerobic Exercise to Slow Parkinson’s Disease Trial

BOOST-PD A Naturalistic Study on IPX-203 for Parkinson’s Disease

Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease

Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)

Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson’s Disease

Phase 1/2a Study of ANPD001 in Parkinson Disease

DB RCT for Specialized Phototherapy in Parkinson’s Disease.

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Parkinson Disease

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps